Finasteride and Male Breast Cancer - A Register-Based Nested Case-Control Study in Denmark, Finland, Norway, and Sweden
Phase of Trial: Phase IV
Latest Information Update: 13 Dec 2017
At a glance
- Drugs Finasteride (Primary)
- Indications Male breast cancer
- Focus Adverse reactions
- Sponsors Merck & Co; Merck Sharp & Dohme
- 08 Dec 2017 Status changed from active, no longer recruiting to completed.
- 01 Dec 2017 Planned End Date changed from 1 Apr 2018 to 30 Nov 2017.
- 08 Sep 2017 Planned End Date changed from 1 Oct 2017 to 1 Apr 2018.